Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 7,245.0 | 5,896.0 | 4,519.0 | 3,460.0 | 2,608.8 | 1,918.5 | 1,391.0 | 1,005.5 |
| Revenue growth | 22.9% | 30.5% | 30.6% | 32.6% | 36.0% | 37.9% | 38.3% | 47.3% |
| Cost of goods sold | 1,573.0 | 1,353.0 | 987.0 | 796.0 | 622.7 | 499.9 | 399.0 | 329.4 |
| Gross profit | 5,672.0 | 4,543.0 | 3,532.0 | 2,664.0 | 1,986.2 | 1,418.6 | 992.0 | 676.1 |
| Gross margin | 78.3% | 77.1% | 78.2% | 77.0% | 76.1% | 73.9% | 71.3% | 67.2% |
| Sales and marketing | 2,814.0 | 2,292.0 | 1,855.0 | 1,534.0 | 1,203.1 | 895.0 | 660.0 | 498.4 |
| Research and development | 1,768.0 | 1,397.0 | 1,024.0 | 749.0 | 529.5 | 377.5 | 285.2 | 217.4 |
| General and administrative | 735.0 | 597.0 | 454.0 | 339.0 | 296.0 | 210.5 | 158.9 | 126.6 |
| EBITA | 355.0 | 333.0 | 245.0 | 77.0 | -17.4 | -44.7 | -367.1 | -154.6 |
| EBITA margin | 4.9% | 5.6% | 5.4% | 2.2% | -0.7% | -2.3% | -26.4% | -15.4% |
| Amortization of intangibles | | 76.0 | 46.0 | 35.0 | 25.0 | 19.7 | 15.1 | 11.8 |
| EBIT | 355.0 | 257.0 | 199.0 | 42.0 | -42.4 | -64.4 | -382.2 | -166.4 |
| EBIT margin | 4.9% | 4.4% | 4.4% | 1.2% | -1.6% | -3.4% | -27.5% | -16.5% |
| Pre-tax income | 399.0 | 249.0 | 150.0 | 67.0 | -39.0 | -113.4 | -410.4 | -193.0 |
| Income taxes | 74.0 | 19.0 | 31.0 | -560.0 | -12.3 | 3.4 | 3.8 | 5.4 |
| Tax rate | 18.5% | 7.6% | 20.7% | | 31.6% | | | |
| Earnings from continuing ops | 325.0 | 230.1 | 118.5 | 626.7 | -26.7 | -116.8 | -414.2 | -198.4 |
| Earnings from discontinued ops | | 230.0 | 119.0 | 627.0 | | | | |
| Net income | 325.0 | 230.1 | 118.5 | 626.7 | -26.7 | -116.8 | -414.2 | -198.4 |
| Net margin | 4.5% | 3.9% | 2.6% | 18.1% | -1.0% | -6.1% | -29.8% | -19.7% |
| |
| Diluted EPS | $1.59 | $1.13 | $0.59 | $3.18 | ($0.15) | ($0.68) | ($2.52) | ($1.27) |
| Shares outstanding (diluted) | 204.0 | 203.2 | 202.5 | 197.2 | 177.8 | 171.2 | 164.5 | 155.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|